Zimmer Biomet (NYSE:ZBH) said today it launched the PrimaGen advanced bone allograft designed as an allogeneic bone graft substitute for use in the repair, replacement, reconstruction or supplementation of tissue in muscuoloskeletal defects.
The Warsaw, Ind.-based company said the PrimaGen advanced allograft contains the same bone healing elements as autografts while eliminating the risks associated with donor site morbidity or harvest site complications.
“PrimaGen Advanced Allograft was developed to overcome the limitations of other bone graft substitutes and designed to offer a real alternative to autograft. We are pleased to include within our Spine portfolio a graft that not only has desirable handling characteristics, but is simple and convenient to use. PrimaGen Advanced Allograft recreates the Gold Standard, while reducing the co-morbidities tied to graft harvest,” spine, dental, CMF & thoracic group prez Adam Johnson said in a press release.
The newly launched PrimaGen advanced is composed of a combination of cortical bone fibers with verified osteoinductivity and cancellous bone to provide trabecular structure for bony ingrowth, the company said.
“The syringe allows for easy preparation and replication of the graft consistency prior to each use,”Dr. Donald Kucharzyk of Crown Point, Ind.’s Orthopaedic, Pediatric and Spine Institute said in a prepared statement.
In November, Zimmer-Biomet said it launched its Comprehensive Vault Reconstruction System, a patient-matched glenoid implant.
The newly launched device is designed to treat patients with severely deficient rotator cuff and extensive bone loss which precludes the use of standard glenoid baseplates, the company said.